Recently, Hong Kong stocks have fluctuated repeatedly. After the Hang Seng Index recovered 24,000 points, the continuation of the market rebound and the direction of allocation became the focus of institutional attention. Analysts believe that the return of capital to the south and the restoration of market sentiment provide support for a short-term rebound, yet overseas interest rates and fundamental restrictions still need to be relaxed. Allocation should be balanced, using dividend assets as a base position, and at the same time combining industrial catalysis and performance delivery to seize structural opportunities in the direction of technology and innovative drugs.

Recently, Hong Kong stocks have fluctuated repeatedly. After the Hang Seng Index recovered 24,000 points, the continuation of the market rebound and the direction of allocation became the focus of institutional attention. Analysts believe that the return of capital to the south and the restoration of market sentiment provide support for a short-term rebound, yet overseas interest rates and fundamental restrictions still need to be relaxed. Allocation should be balanced, using dividend assets as a base position, and at the same time combining industrial catalysis and performance delivery to seize structural opportunities in the direction of technology and innovative drugs.